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POMP39 is a protein dually 
localized to the mitochondrial 
outer membrane (MOM) and the 
flagellum of T. brucei. Its sub-or-
ganellar localization depends on 
acylation.
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ABSTRACT: 
A subclass of eukaryotic proteins is subject to modification with fatty acids, the 
most common of which are palmitic and myristic acid. Protein acylation allows 
association with cellular membranes in the absence of transmembrane 
domains. Here we examine POMP39, a protein previously described to be 
present in the outer mitochondrial membrane proteome (POMP) of the 
protozoan parasite Trypanosoma brucei. POMP39 lacks canonical 
transmembrane domains, but is likely both myristoylated and palmitoylated on 
its N-terminus. Interestingly, the protein is also dually localized on the surface 
of the mitochondrion as well as in the flagellum of both insect-stage and the 
bloodstream form of the parasites. Upon abolishing of global protein acylation 
or mutation of the myristoylation site POMP39 relocates to the cytosol. RNAi-
mediated ablation of the protein neither causes a growth phenotype in insect-
stage nor bloodstream form trypanosomes. 
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1. INTRODUCTION 
African trypanosomes are unicellular, flagellated eukaryotic parasites that are 
transmitted by the Tsetse fly during a blood meal. During their complex life 
cycle trypanosomes switch their surface coat and modulate many cellular 
functions. As bloodstream forms (BSF) trypanosomes cause sleeping 
sickness in humans and nagana in cattle. Besides their clinical importance 
trypanosomes are also excellent model systems to study basic biological 
processes. One reason for this is that, unlike the common model organisms 
mouse, flies, worms and yeast, which belong to the eukaryotic supergroup of 
the Opisthokonta, trypanosomes are representatives of the supergroup of the 
Excavata (Simpson and Roger, 2004). This unique position in the eukaryotic 
evolutionary tree results in many special features in their biology, many of 
which concern mitochondrial biogenesis. As a consequence, African 
trypanosomes have recently been subjected to sub-cellular and sub-
organellar proteomics approaches scrutinizing the protein inventory of 
mitochondria and their membranes (Acestor et al., 2009; Niemann et al., 
2013; Panigrahi et al., 2009), the mitochondrial ribosomes (Zikova et al., 
2009) and the respiratory chain (Acestor et al., 2009). Moreover, the 
composition of the flagellum has also been analyzed in detail (Broadhead et 
al., 2006; Oberholzer et al., 2011). These comprehensive proteomics 
approaches have greatly increased the knowledge about the sub-cellular 
localization of a large fraction of trypanosomal proteins and resulted in an 
increasing number of proteins that have been detected in two or more cellular 
compartments. However, it is often unclear whether this reflects cross-
contamination that is inherent in many biochemical purifications or whether 
these proteins are genuinely dually localized and moonlight in an alternative 
sub-cellular context  (Collingridge et al., 2010). In a recent study we have 
raised the protein inventory of the mitochondrial outer membrane (MOM) of T. 
brucei by combining sub-organellar fractionation with correlated protein 
abundance profiles and statistical analysis (Niemann et al., 2013). Out of the 
82 MOM proteins identified, only 30 have predicted transmembrane helices 
and five belong to the ß-barrel protein family (Niemann et al., 2013). Thus, 47 
MOM proteins have no canonical membrane-spanning domain, leading to the 
question as to how these proteins associate with the MOM.  
Aside from hydrophobic -helical domains, protein modifications with fatty 
acids provide a mechanism to anchor proteins to membranes. There are 
many different ways of how proteins can be acylated; among them the 
covalent modification of an N-terminal glycine residue with myristate (a 14-
carbon chain fatty acid) probably represents the best-characterized protein 
fatty acid modification. Proteins with the N-terminal consensus sequence 
MGXXXS/T (Maurer-Stroh et al., 2010a; Maurer-Stroh et al., 2010b; Towler et 
al., 1988) are subject to this irreversible modification, which is carried out by 
the enzyme myristoyl-CoA:protein N-myristoyltransferase (NMT) (Bhatnager 
et al., 1999; Farazi et al., 2001), usually in a co-translational fashion (Martin et 
al., 2011). Whereas myristoylation of a protein increases its hydrophobicity 
and thus its membrane affinity, this single acylation is considered insufficient 
for anchoring a protein stably to a membrane (Peitzsch and McLaughlin, 
1993). Monomyristoylated proteins can thus only transiently associate with 
membranes.  
Reversible S-acylation represents another way to lipidate a protein. S-
acylation consists of the modification of a cysteine side chain with a fatty acid, 
most frequently palmitate, the carbon chain of which is longer than myristate. 
Palmitoylation is catalyzed by the enzyme palmitoyl-acyltransferase (PAT). 
Multiple PATs and target proteins have been described, e.g. 23 PATs and 
>250 targets in mammalian cells and 7 PATs and >50 targets in yeast (for 
reviews see e.g. (Greaves and Chamberlain, 2011; Hannoush and Sun, 2010; 
Mitchell et al., 2006; Nadolski and Linder, 2007). Moreover, thioester-bound 
fatty acids including palmitate can be removed by the activity of acyl protein 
thioesterase (APT) (Duncan and Gilman, 2002; Zeidman et al., 2009). Thus, 
in contrast to the co-translational and irreversible myristoylation that generally 
is mediated by a single NMT, the palmitoylation is reversible, occurs post-
translational and is catalyzed by multiple PATs. Many proteins are dually 
acylated, which allows them to stably associate membranes (Nadolski and 
Linder, 2007). The interplay of myristoylation and palmitoylation and the 
resulting implications for protein routing, trafficking and dynamic regulation of 
protein localization are poorly understood. However, the kinetic membrane-
trapping model (Shahinian and Silvius, 1995) provides a mechanism of how 
cycles of acylation-deacylation by PATs and thioesterases might regulate sub-
cellular localization of fatty acid modified proteins (Goodwin et al., 2005; 
Rocks et al., 2005; Shahinian and Silvius, 1995).  
In kinetoplastids, the dual acylation with myristate and palmitate has been 
linked to flagellar localization of proteins (Emmer et al., 2009; Liu et al., 2010, 
for a review of acylation in trypansomatids see Goldston et al., 2014). Another 
study shows that dual acylation is associated with the localization to the 
endomembrane system (Mills et al., 2007). Here we present evidence for the 
acylation of a protein that is dually localized to both, the MOM and the 
flagellum of T. brucei. The membrane-association of the polypeptide termed 
POMP39 (present on the mitochondrial outer membrane proteome #39; 
Niemann et al., 2013) likely depends on the dual acylation at the N-terminus 
of the protein. In summary our result suggest that protein acylation represents 
a versatile mechanism to allow association with different membranes within 
the same cell. 
2. MATERIAL AND METHODS 
2.1 Cell lines 
Insect-stage (procyclic form, PCF) T. brucei cell lines were generated using 
strain 29-13 (Wirtz et al., 1999) and were grown at 27°C in SDM79 (Brun and 
Schönenberger, 1979) supplemented with 10% (w/v) fetal calf serum. 
Transgenic BSF T. brucei are based on the single marker strain (Wirtz et al., 
1999). BSF cultures were grown in HMI-9 (Hirumi and Hirumi, 1989) at 37°C 
and 5% CO2 atmosphere. POMP39 was tagged with a triple c-myc epitope at 
both the N- and C-terminus using a pLew-100 (Wirtz et al., 1999) derivative 
and puromycin as selection marker. The RNAi is directed against the ORF 
Tb927.8.2070, but due to the sequence similarities (see SupFig.1 and 
SupFig.2 ) all of the four putative isoforms are simultaneously affected by the 
RNAi. Collectively we refer to POMP39 RNAi throughout the manuscript. The 
RNAi construct was generated based on a pLew-100 stem-loop construct 
(Wirtz et al., 1999) with blasticidin as selection marker using a 433bp-insert 
(nucleotides 158-591 of Tb927.8.2070). The TbNMT RNAi cell line was 
described by Price et al., 2003. Transfection of the constructs was done as 
described (McCulloch et al., 2004). 
2.2 Subcellular Fractionation and Western Blot 
Preparation of mitochondrial vesicles at isotonic conditions was carried out as 
described in detail by Schneider et al., 2007a. Digitonin fractionation was 
performed as specified in Schneider et al., 2007b. Carbonate extraction was 
done as demonstrated in Fujiki et al., 1982 but using a Beckman Airfuge for 
pelleting at 100.000g for 20min. Protein samples were analyzed using 
standard procedures for SDS-PAGE and western blotting. Polyclonal antisera 
from rabbits were diluted in phosphate buffered saline (1xPBS) containing 
0.1% (v/v) Tween and 3% (w/v) milk powder as follows: VDAC (voltage-
dependent anion channel) 1:1000, cyC (cytochrome C) 1:100, cyC1 
(cytochrome C1) 1:1000, ATOM40 (archaic translocase of the MOM) 1:10.000, 
LDH (dihydrolipoamid-dehydrogenase, gift of L. Krauth-Siegel, Heidelberg) 
1:10.000, mHSP70 (mitochondrial heat shock protein 70, gift of Rob Jensen, 
Baltimore). Commercially available monoclonal mouse antibodies anti EF1a 
(eukaryotic elongation factor 1a; Upstate/Merck Millipore) and anti c-myc 
(Santa Cruz Biotech) were diluted 1:10.000 and 1:1000. Western blots were 
visualized with the Odyssey Clx infrared imaging system from Li-Cor 
Biosciences.  
2.3 Immunofluorescence 
Immunofluorescence was carried out according to standard protocols. Briefly, 
ca. 0.5-1x107 PCF or BSF cells were harvested, washed twice in 1xPBS and 
adhered to the glass slide for 10min. The cells were then fixed in 
1xPBS/4%(w/v) paraformaldehyde for 10min and permeabilized in 1xPBS/2% 
(w/v) Triton-x-100 for 10min. The slides were incubated with the primary and 
secondary antibodies for one hour each. The antibody incubations were each 
followed by five two-minute washes with 1xPBS. All steps were carried out in 
a wet chamber at room temperature in the dark. Finally, the slides were 
submerged in ice-cold methanol for three min and air-dried. Slides were 
mounted with DAPI-containing (1.5µg/µL) Vectashield (Vector Laboratories) 
and imaged with a Leica DMI6000 B microscope equipped with a modified 
light source to visualize the infrared spectrum. Antisera/antibodies were 
diluted in 1xPBS as follows: c-myc 1:100; ATOM40 1:1000; FITC conjugated 
to goat anti-rabbit 1:100 (Sigma); IRDye 680LT conjugated to goat anti-mouse 
1:100 (Li-Cor Biosciences).  
2.4 Northern Blot 
To ascertain the tetracycline-inducible (tet) RNAi-mediated gene ablation of 
POMP39, RNA was isolated from uninduced cells and 48hrs post-induction. 
Northern blot was performed as described (Tan et al., 2002). 
3. RESULTS 
3.1 POMP39 is likely myristoylated and palmitoylated. 
The protein POMP39 was found as component of the MOM proteome in PCF 
trypanosomes that combined biochemical fractionation with quantitative mass 
spectrometry (Niemann et al., 2013). It is encoded by four nearly identical 
ORFs (Tb927.8.2070, Tb927.8.2260, Tb927.8.2270, Tb927.8.2280), which 
differ by 2-7 amino acids among each other (see SupFig. 1). We thus refer to 
―POMP39‖ for all four potential isoforms. BLAST analysis shows that the 
protein has an orthologue in T. brucei gambiense and T. evansi, but not in 
other trypanosomatids or in any other species. Sequence analysis with 
HHPred (Biegert et al., 2006) suggests that POMP39 may have a region 
sharing vague similarity with a phosphodiesterase domain although most 
amino acids are missing or replaced in the predicted active site, which 
suggests that it cannot be active. POMP39 has neither a predicted 
transmembrane helix nor a signal anchor. The polypeptide is strongly 
overexpressed in the BSF, as evident from proteomics studies (Bridges et al., 
2008; Gunasekera et al., 2012). 
Bioinformatics analyses suggest that POMP39 is dually acylated (Fig. 1A). 
According to the NMT algorithm (http://mendel.imp.ac.at/myristate/), which 
predicts myristoylation sites, the glycine residue on the second position (G2) 
is subject to myristoylation with a high level of confidence (probability of false 
positive 0.03%). The cysteine residue on position three (C3) is a predicted 
palmitoylation site with ≥95% confidence level when analyzed using the CSS-
Palm algorithm (Ren et al., 2008). Consistent with this prediction, POMP39 
was identified as one of 124 proteins enriched by streptavidin chromatography 
following an acyl-biotin exchange-reaction of whole cell lysates (Emmer et al., 
2011). Notably, this streptavidin-capture of POMP39 was hydroxylamine-
sensitive. This substantiates the presence of an S-acylation on the POMP39 
polypeptide. Thus, POMP39 is likely one of the <2% proteins of the ca. 7500 
proteins in T. brucei that is palmitoylated.  
To verify these findings, cell lines expressing three epitope-tagged variants of 
POMP39 were generated (Fig. 1B). The protein was tagged with the triple c-
myc epitope on its N- (myc-POMP39) and its C-terminus (POMP39-myc). To 
abolish both fatty acid modifications, a variant of the C-terminally tagged 
POMP39 was generated lacking the first four amino acids including both 
putative acylation sites (∆4-POMP39-myc). Immunoblots of whole cell extracts 
resolved by SDS-PAGE from cell lines expressing the three tagged proteins 
revealed that the C-terminally tagged version migrates faster than the N-
terminally tagged protein (Fig. 1B). Moreover, the deletion mutant shows the 
same mobility as the N-terminally tagged variant (Fig. 1B). Since acylated 
proteins are known to show an increased electrophoretic mobility on SDS 
PAGE (Lodge et al., 1997), the faster migrating c-terminally tagged POMP39 
is likely acylated. In such a scenario the other two tagged POMP39 variants 
would not be acylated since the acylation site is masked by the myc-tag in 
myc-POMP39 or absent in ∆4-POMP39-myc. 
It has previously been shown that N-terminal myristoyl-transferase (TbNMT) is 
responsible for essentially all protein myristoylation in T. brucei (Price et al., 
2003). In order to directly investigate the putative myristoylation of POMP39 
we produced an RNAi cell line allowing inducible ablation of TbNMT with 
simultaneous expression of C-terminally tagged POMP39 (POMP39-myc). In 
this cell line, the addition of tetracycline triggers both, the expression of 
POMP39-myc as well as the ablation of TbNMT. As expected, the ablation of 
TbNMT leads to a growth arrest after around >90hrs of induction and 
ultimately to the death of the parasites (Fig. 1C) (see Price et al., 2003). 
During induction samples of digitonin extracts of total cells were collected and 
analyzed by SDS-PAGE. The result in Fig. 1C shows that concomitant with 
the appearance of the growth phenotype the electrophoretic mobility of 
POMP39-myc changes towards slower migration, which, as shown in Fig. 1B, 
is consistent with the lack of acylation. The fact that the migration of the 
protein in induced cells essentially matches the one observed for ∆4-
POMP39-myc protein (Fig. 1B) suggests that it has lost both acyl groups. 
TbNMT is only essential for myristoylation but not for palmitoylation, 
suggesting that in the absence of the myristate the palmitoyl-group gets 
rapidly turned over or is not attached in the first place. The increase in the 
amount of the tagged POMP39 is due to ongoing induction of the expression 
of the tagged POMP39. The altered electrophoretic mobility upon TbNMT 
knockdown thus is indicative of the presence of the myristoylation of POMP39.  
Carbonate extraction at high pH disrupts the interaction between membranes 
and peripherally associated proteins, and therefore can be used to distinguish 
them from membrane-integral proteins (Fujiki et al., 1982). POMP39 lacks 
predicted transmembrane domains and therefore would be expected to 
behave as a soluble protein in a carbonate extraction experiment, despite the 
presence of the myristoylation — which alone would not be sufficient to confer 
membrane integrity. However, in case POMP39 is dually acylated it would be 
expected to behave like a membrane-integral protein and should be 
recovered in the pellet. In order to test the acylation status of POMP39, 
mitochondrial vesicles from cells expressing POMP39-myc were isolated at 
isotonic conditions to keep the MOM intact (Schneider et al., 2007a) and 
subjected to carbonate extraction. Fig. 1D shows that POMP39-myc behaves 
like the membrane-integral protein VDAC (voltage-dependent ion channel), 
whereas the peripheral membrane protein cyC (cytochrome c) was 
exclusively recovered in the soluble fraction. The carbonate extraction thus 
indicates the presence of an additional acylation of POMP39 other than the 
putative myristoylation. Collectively, the data shown in Fig. 1 imply that 
POMP39 is dually acylated, namely probably myristoylated at position G2 and 
most likely palmitoylated at position C3. 
3.2 POMP39 localizes to mitochondria and flagella 
POMP39 was originally identified as a component of the MOM proteome. The 
strategy to identify MOM proteins was based on protein abundance profiling 
using mitochondrial sub-fractions. In combination with statistical analysis this 
allowed us to define a cluster of proteins that are localized to the MOM with 
high confidence (Niemann et al., 2013). Proteins that are localized to more 
than one compartment would in this study also be scored as MOM proteins, 
provided that the ―second‖ localization would be in a fraction that was not 
included in our analysis. Thus, in order to determine the intracellular 
localization of POMP39 in more detail we employed a cell fractionation 
protocol (Fig. 2A upper panel). Briefly, the cells were lysed using nitrogen 
cavitation (WC). The crude cytosol (SN1) was separated from the 
membranous fraction (P1) and upon differential centrifugation crude 
mitochondria were obtained (crude mito). In a last step, the crude 
mitochondrial fraction was purified by using a discontinuous nycodenz 
gradient to obtain pure mitochondria (―pure mito‖, see detailed description in 
Schneider et al., 2007a). Western blots of the fractionation show that 
mitochondrial proteins are most enriched in the ―pure mito‖ fraction, as is 
evident by comparing the mitochondrial marker proteins ATOM40, cy C, cy C1 
and mHSP70, which localize to the four different mitochondrial sub-
compartments OM, IMS (intermembrane space), IM (inner membrane) and 
matrix (Fig. 2A upper panel, lane ―pure mitos‖). The cytosolic marker 
eukaryotic elongation factor 1a (EF1a) is most enriched in the cytosol (SN1) 
and is depleted in the ―pure mito‖ fraction (Fig. 2A upper panel). POMP39-
myc is not enriched in any particular fraction and thus behaves different from 
both mitochondrial and cytosolic markers. This strongly suggests that 
POMP39 is present in mitochondria as well as in other compartments. This is 
even more evident when comparing the quantification of these western blot 
enrichment profiles (Fig. 2A lower). While ATOM40 (MOM) and cy C (IMS) 
clearly enrich maximally in the ―pure mito‖ fraction, POMP39 is not enriched 
from ―crude‖ to ―pure mito‖ and its profile closely resembles the signal of PFR, 
a flagellar marker. In an alternative fractionation procedure based on 
digitonin-extraction of whole cells (Schneider et al., 2007b) POMP39-myc is 
quantitatively recovered in the pellet in which mitochondria and cytoskeletal 
components are enriched (Fig 2B upper panel).  
To further investigate the sub-cellular localization of POMP39 
immunofluorescence (IF) was used. The lower panel of Fig 2B shows that the 
main signal for POMP39-myc appears in the flagellum, with a weaker and 
diffuse staining of the whole cell body. These results show that another 
localization of POMP39 seems to be the flagellum. The mitochondrial 
localization of POMP39 could neither be confirmed nor excluded in this 
analysis. While flagella are known contaminants of mitochondrial preparations, 
the purest MOM fraction we prepared was free of flagellar contamination 
(Niemann et al., 2013). Consequently, the cluster corresponding to the MOM 
proteome does not contain any known flagellar proteins. In order to further 
verify that one localization of POMP39 is the MOM, we revisited the mass 
spectrometry (MS)-based normalized protein abundance profiles that were 
used to define the MOM proteome of which POMP39 is a component 
(Niemann et al., 2013). If POMP39 would be a resident flagellar protein that 
during cell fractionation would associate with the MOM in an artefactual way, 
other double acylated flagellar proteins should do the same. However, this is 
not the case as evidenced in Fig. 2C in which the normalized abundance 
profiles of POMP39 were compared to the one of TbCALp1.3 (Tb927.1.2120), 
a putative calpain. Many calpains are flagellar proteins (Liu et al., 2010) and 
TbCALp1.3 has been identified in the flagellar membrane and flagellar matrix 
proteome of the BSF. Moreover, the protein has the same N-terminal MGCG-
sequence as POMP39 and therefore is predicted to be myristoylated and 
palmitoylated. Finally, TbCALp1.3 was also shown to be palmitoylated by 
acyl-biotin exchange/streptavidin capture, just as POMP39 (Emmer et al., 
2011). As depicted by the black line in the graph of Fig. 2C, POMP39 has a 
relative abundance maximum in the ―pure MOM‖ fraction, whereas in the 
―crude ER‖ fraction it is approximately 3-fold depleted (Fig. 2C). For 
TbCALp1.3 however, we find the converse, its maximum abundance is in the 
―crude ER‖ fraction and 3-fold less of the protein is found in the ―pure MOM‖ 
fraction. Noteworthy, a flagellar fraction was not part of this analysis. In 
summary, although both POMP39 and TbCALp1.3 are dually acylated and 
found in the flagellum, TbCALp1.3 fractionates very different from POMP39. 
We therefore conclude that POMP39 is a genuine, dually localized protein 
that is found in both, the MOM and the flagellum. Another example is an EF-
Hand containing putative protein phosphatase. The protein is also dual 
acylated by myristate and palmitate. In Leishmania major the protein was 
shown to localize to the endomembrane system and the flagellar pocket (FP) 
by IF (Mills et al., 2007). Consistent with this observed localization, the 
trypanosome orthologue encoded by Tb927.1.4050 (ca. 60% identity) was in 
our proteomics study never found in the mitochondrial fraction and had the 
relative maximal intensity in the crude ER fraction (Niemann et al., 2013). 
Furthermore, it was not detected in the flagellar proteome (Oberholzer et al., 
2011).  
3.3 Lack of global myristoylation causes accumulation of POMP39 in the cell 
body 
Next, we were investigating whether the putative acylation(s) influence the 
localization of POMP39. To that end, immunofluorescence analysis of the cell 
line that allows for simultaneous down-regulation of TbNMT and expression of 
POMP39-myc (Fig. 1C) was carried out. The results in Fig. 3 show that in 
uninduced cells POMP39-myc cannot be detected, as expected serving as a 
negative control. 24hrs post-induction of TbNMT RNAi the majority of the 
protein localizes to the flagellum, whereas a fraction is found in the cell body. 
Finally, the signal in the flagellum diminishes and more of POMP39-myc 
accumulates in the cell body (Fig 3, left to right panel). The localization of the 
N-terminally tagged myc-POMP39 and the C-terminally tagged deletion 
mutant ∆4-POMP39-myc confirmed these results. Both protein variants co-
fractionate with soluble cytosolic markers in digitonin extractions (Fig. 4A and 
B, upper panel). Moreover, immunofluorescence experiments confirm the 
cytosolic localizations of these proteins to the cell body (Fig. 4A and B, lower 
panel).  
POMP39 is strongly upregulated in the disease-causing BSF of the parasite 
(Gunasekera et al., 2012; Urbaniak et al., 2012). Consequently, the 
subcellular localization of POMP39 was also investigated in the BSF. Fig. 4C 
and D show the results of the digitonin fractionation and the IF analysis of 
POMP39-myc in BSF trypanosomes. As in the PCF, the C-terminally tagged 
variant POMP39-myc fractionates with the mitochondrial marker in digitonin 
extractions (Fig 4C, upper panel) and shows a mainly flagellar localization 
when analyzed by immunofluorescence (Fig 4C, lower panel). Moreover, as 
evident form Fig 4D, the localization changes when the tag is placed on the N-
terminus and therefore the acylation is abolished: the protein fractionates now 
with cytosolic markers in digitonin extractions (Fig D, upper panel) and has 
lost its flagellar localization as visualized by immunofluorescence (Fig 4D, 
lower panel). In summary, these results show that the presence of the 
putative fatty acid(s) is required for proper localization of POMP39 to both the 
flagella and the MOM.  
3.4 POMP39 has a non-essential function. 
To investigate the function of POMP39 the protein was subjected to RNAi-
mediated ablation in both PCF and BSF trypanosomes. Fig. 5 shows that the 
growth curves for induced and uninduced cells are virtually identical. Even 
though the RNAi knockdown is efficient as indicated by Northern blots 
ablation of the POMP39 mRNAs does not affect growth in neither the PCF 
(Fig 5A) nor BSF (Fig 5B). Growth at elevated temperature (33°C) in the PCF 
was also unaffected by the depletion of POMP39. Thus, POMP39 has a non-
essential, unknown function under the tested growth conditions or the residual 
amount of POMP39 that is still present in the induced RNAi cell lines is 
sufficient to support normal growth.  
4. DISCUSSION 
POMP39 was identified as a component of the MOM proteome in PCF 
trypanosomes (Niemann et al., 2013), whereas two earlier proteomic studies 
of mitochondria and their membranes in PCF T. brucei failed to detect the 
protein (Acestor et al., 2009; Panigrahi et al., 2009). POMP39 was also 
identified in the flagellar matrix proteome of BSF trypanosomes (Oberholzer et 
al., 2011), hinting that it might be dually localized. POMP39 contains both a 
predicted myristoylation and palmitoylation site (99.97% and ≥95% certainty, 
respectively). The data compiled here suggest that POMP39 is indeed a dual 
acylated protein, since myristoylation alone does not suffice to confer 
resistance to carbonate extraction (Peitzsch and McLaughlin, 1993). The 
myristoylation of POMP39 was interrogated by TbNMT knockdown, which 
abolishes all myristoylation in T. brucei. The TbNMT knockdown resulted in a 
shift of electrophoretic mobility of POMP39 and a concomitant change of 
localization, whereas the putative palmitoylation was experimentally 
addressed in a previous study (Emmer et al., 2011). In line with the global 
proteomics studies mentioned above (Acestor et al., 2009; Panigrahi et al., 
2009; Oberholzer et al., 2011), we show that a fraction of the protein localizes 
to the flagellum, whereas another fraction is stably associated with the MOM.  
A survey of the trypanosomal MOM proteome reveals other candidates that 
might be acylated. Besides POMP39 there is a single protein, POMP3 
(Tb927.9.2670) that is predicted to be dual acylated by myristoylation and 
palmitoylation. POMP3 has two predicted transmembrane helices and has 
neither been found in the flagellar nor the mitochondrial proteome before 
(Acestor et al., 2009; Oberholzer et al., 2011; Panigrahi et al., 2009), but the 
palmitoylation was experimentally confirmed (Emmer et al., 2011). The 
function of POMP3 is unknown and the protein is only present in 
trypanosomatids. However, BLAST searches suggest it may have weak 
homology to the central domain of the human engulfment and cell motility 
domain protein 2. 
Two proteins of the MOM proteome are predicted to be myristoylated. 
POMP20 (Tb927.10.9140) is annotated as a hypothetical conserved protein, 
with high similarity to FAD-dependent oxidoreductases. It has been assigned 
to mitochondria before (Panigrahi et al., 2009), but was not identified in the 
flagellar proteome (Oberholzer et al., 2011). The second protein predicted to 
be myristoylated is the arginine kinase TbAK1 (Tb927.9.6170). TbAK1 is part 
of the phosphoarginine energy-buffering system and the C-terminally c-myc 
tagged protein localizes to the flagellum in both PCF and BSF trypanosomes 
(Voncken et al., 2013). However, biochemically the protein was not detected 
in the flagellar proteome (Oberholzer et al., 2011) but in mitochondrial 
membranes instead (Acestor et al., 2009). 
Three proteins of the MOM proteome are palmitoylated (Emmer et al., 2011). 
These are fatty acyl CoA synthase 4 (ACS4, Tb927.9.4230), a CAAX prenyl 
protease, (Tb927.11.3120) and POMP12 (Tb927.11.2750) a trypanosomatid-
specific protein of unknown function. ACS4 was identified in the mitochondrial 
membranes (Acestor et al., 2009) and in the flagellar proteome (Oberholzer et 
al., 2011), while the CAAX prenyl protease was only found to be associated 
with the proteomes of the mitochondrial membranes (Acestor et al., 2009). 
POMP12 on the other hand was neither associated with mitochondria nor with 
flagella in either study (Acestor et al., 2009; Oberholzer et al., 2011; Panigrahi 
et al., 2009). These results suggest that up to 10% of all MOM proteins are 
acylated and that some of them, similar to POMP39 investigated in the 
present study, might be dually localized.  
While in trypanosomatids many acylated proteins are at least in part localized 
in flagella, they are generally found in the endomembrane system in 
mammalian cells. Mitochondrial localization of acylated proteins is unusual but 
not without precedent. One example is the NADH ubiquinone oxidoreductase 
of the mitochondrial inner membrane (Walker et al., 1992). Another example 
is the myristoylated protein NADH-cytochrome b5 reductase, which in 
mammalian cells localizes to both, the MOM and the ER (Borgese et al., 
1980; Borgese et al., 1986; Borgese and Pietrini, 1980). The protein is 
inserted post-translationally into the ER and the MOM using a N-terminal 
anchor and apparently is myristoylated in both of these compartments 
(Borgese and Longhi, 1990). It was further shown that when the myristoylation 
site on the N-terminus was abolished by changing the second amino acid 
from glycine alanine (G2A), the protein is released from the MOM, but 
remained associated with the ER (Borgese et al., 1996).  
How could POMP39 be routed and distributed to both, the MOM and the 
flagellum? Protein import into mitochondria has been investigated in great 
detail mainly in yeast. In general, protein import across - or insertion into - the 
MOM is mediated by a protein complex termed TOM (translocase of the 
MOM; for recent reviews see e.g. (Becker et al., 2009; Schmidt et al., 2010). 
Trypanosomes have an unusual TOM complex, the central component of 
which is ATOM40 (ATOM = archaic translocase of the MOM, see Pusnik et al., 
2011; Harsman et al., 2012; Mani et al., 2015). Interestingly, the association 
of POMP39 with mitochondria remains unaltered upon RNAi-mediated 
knockdown of ATOM40 (data no shown). Thus, as might be expected for an 
acylated protein that lacks a membrane-spanning domain, POMP39 
localization to the MOM is independent of the protein import machinery. 
Flagellar targeting of membrane proteins is not very well understood 
(summarized in e.g. Emmer et al., 2010 and Goldston et al., 2014). However, 
as stated above, in trypanosomes many flagellar proteins are acylated 
(Emmer et al., 2009; Liu et al., 2010), but whether and how the acylation is 
connected to targeting is not known. A recent hypothetical model suggests 
that the interplay of NMT, PAT(s) and the presence of a characteristic 
polybasic region (KKKK) determines, whether dually acylated proteins are 
targeted to the flagellar or the pellicular membrane (Goldston et al., 2014). 
The polybasic KKKK stretch, however, is absent from POMP39. 
As discussed above POMP39 is likely both, myristoylated and palmitoylated. 
Palmitoylation is catalyzed by palmitoylacyltransferase (PATs). Twelve PATs 
and more than 120 target proteins for palmitoylation have been identified in T. 
brucei (Emmer et al., 2009; Emmer et al., 2011). However, so far only one 
PAT, TbPAT7, could be assigned to a specific substrate. TbPAT7 is non-
essential for growth, but required for palmitoylation and subsequent flagellar 
targeting of calflagin (Emmer et al., 2009). Proteomic profiles of organellar 
fractions suggest distinct subcellular localization of the trypanosomal PATs. 
Interestingly, one PAT (TbPAT5) was detected in the highly pure MOM 
fraction (Niemann et al., 2013). It is thus tempting to speculate that a 
myristoylated variant POMP39 is palmitoylated by TbPAT5 associated with 
the MOM, and that this would provide a mechanism for membrane insertion. 
Palmitoylation is reversible through the action of acyl protein thioesterase 
(APT), as was shown in yeast (Duncan and Gilman, 2002). Cycles of 
acylation/deacylation could thus play an important role in targeting of 
POMP39 as well. In T. brucei, these thioesterases have not been 
characterized yet. BLAST search of APT1 (YLR118C) of S. cerevisiae against 
the T. brucei genome reveals as best hit Tb927.8.6390. This protein is 
annotated as putative lysophospholipase and was found to associate with 
both, mitochondria and flagella (Acestor et al., 2009; Panigrahi et al., 2009). 
Our protein abundance profiles also indicate a mitochondrial association 
(Niemann et al., 2013), priming this enzyme as a potential candidate for the 
regulation of the mitochondrial localization of POMP39. 
In summary our results suggest that the association of POMP39 with the 
MOM as well as with the flagellar membrane is mediated by acylation. 
Moreover, a bioinformatics survey suggests that acylation might be a more 
general way to anchor proteins into the MOM. 
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FIGURE LEGENDS 
Fig 1. POMP39 is probably myristoylated and palmitoylated. (A) Sketch 
showing the amino acid sequence of the POMP39 N-terminus and the 
putative acylation sites (MYR, myristoylation; PALM, palmitoylation). (B) 
Upper panel, cartoon of the three epitope-tagged variants used in this study. 
The lower panel shows western blots probed for the c-myc epitope (myc) of 
whole cell extracts of cell lines expressing these three tagged proteins. (C) 
Growth curve of the tet-inducible cell line expressing POMP39-myc and 
allowing simultaneous RNAi-mediated knockdown of TbNMT. Lower panel, 
western blot of digitonin-solubilized cell extracts of the POMP39-myc/NMT 
RNAi cell line probed for the c-myc epitope. Cytosolic EF1a serves as a 
loading control. (D) Carbonate extraction of gradient-purified mitochondria 
isolated from the POMP39-myc expressing cell line. VDAC, a beta-barrel 
protein of the MOM and cytochrome C (cy C), a peripheral membrane-
associated protein serve as controls.  
Fig 2. Dual localization of POMP39 to the MOM and to flagella. (A) Upper 
panel, western blots of the sub-cellular fractionation of the POMP39-myc cell 
line to yield gradient-purified mitochondria. 10µg protein were loaded per lane, 
separated by SDS-PAGE, blotted and probed for the c-myc epitope (myc), the 
proteins ATOM40 (MOM), cy C (inter membrane space, IMS), cytochrome C1 
(cy C1, mitochondrial inner membrane, MIM), mitochondrial heat-shock 
protein 70 (mHSP70, matrix), the cytosolic marker EF1a and PFR (para 
flagellar rod, flagellum). The fractions depicted are: whole cells (WC), 
supernatant 1 (SN1), pellet 1 (P1), crude mitochondria (crude mito) and 
gradient-purified mitochondria (pure mito) as described (Schneider et al., 
2007a). Lower panel, quantified and normalized enrichment profiles of 
selected markers from the western blots of the upper panel. (B) Upper panel, 
POMP39-myc expressing cells were subjected to digitonin fractionation. The 
corresponding western blots were probed for myc, mHSP70 and EF1a. The 
fractions depicted are whole cells (Tot), supernatant (sup) and pellet (Pe). (B) 
Lower panel, IF analysis of the POMP39-myc expressing cell line. POMP39-
myc is shown in red. 4’6-Diamidin-2-phenylindol (DAPI) in blue stains the 
nuclear and mitochondrial DNA and ATOM40 shown in green stains the 
mitochondrial network. Bar: 10µm. (C) Graph showing the MS-based, 
normalized protein abundance profile for POMP39 (black line) and TbCALp1 
(grey line). The fractions used are: microsomal fraction (crude ER), pure mito, 
crude MIM, crude MOM, pure MOM and a fraction called ER/MOM. The 
graphs were produced from the data presented in Niemann et al., 2013, which 
also details the fractionation protocol. 
Fig 3. Lack of acylation causes POMP39 to localize to the cell body. (A) 
IF analysis of the inducible TbNMT RNAi cell line expressing the POMP39-
myc stained for POMP39-myc (red), DAPI (blue) and ATOM40 (green). Time 
of induction of RNAi is indicated. Bar: 10µm. 
Fig 4. POMP39 localization likely depends on acylation in both, PCF and 
BSF T. brucei. (A) Digitonin fractionation (upper panel) and IF analysis (lower 
panel) of the PCF cell line expressing N-terminal tagged POMP39 (myc-
POMP39). EF1a serves as cytosolic marker, mHSP0 and dihydrolipoamid-
Figure legends
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dehydrogenase (LDH) serve as mitochondrial matrix marker. Bar: 10µm. (B) 
Digitonin fractionation (upper panel) and IF analysis (lower panel) of the PCF 
cell line expressing the N-terminal deletion mutant with C-terminal c-myc tag 
(∆4-POMP39-myc). (C) POMP39-myc expressed in BSF trypanosomes 
analyzed by digitonin fractionation (upper panel) and IF analysis (lower panel). 
DIC, differential interference contrast. (D) Digitonin fractionation (upper panel) 
and IF analysis (lower panel) of myc-POMP39 in BSF trypanosomes. 
Fig 5. POMP39 has a non-essential function. Growth curves for RNAi-
mediated knockdown of POMP39 in (A) PCF and (B) BSF trypanosomes. 
Superimposed graphs of induced (grey boxes) and non-induced (black boxes) 
cells show virtually identical growth. The insets show the corresponding 
northern blots to verify the absence of the POMP39-mRNA 48hrs post-
induction (+tet), the ethidiumbromide (EthBr) stained rRNAs serve as a 
loading control. 
Sup Fig 1. Amino acid sequence of POMP39 orthologues. Alignment of T. 
brucei brucei (Tbb) POMP39 sequences and the T. brucei gambiense (Tbg) 
POMP39 orthologue. Tb927.8.2070 is most similar to the Tbg927.8.1705 
sequence. The differences are shown in bold red/bold black. 
Sup Fig 2. Nucleotide sequence of POMP39 isoforms. Alignment of T. 
brucei brucei POMP39 sequences (Tb927.8.2070/2260/2270/2280) and the 
region of Tb927.8.2070 that was used to generate the RNAi construct. 
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